[YMAB] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 87.25%
YoY- -146.38%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 18,461 22,798 19,931 23,363 20,454 20,751 20,251 -5.96%
PBT -6,652 -9,149 -6,469 -793 -7,560 -6,123 -6,390 2.70%
Tax 346 100 160 195 187 179 -1,293 -
NP -6,998 -9,249 -6,629 -988 -7,747 -6,302 -5,097 23.45%
Tax Rate - - - - - - - -
Total Cost 25,459 32,047 26,560 24,351 28,201 27,053 25,348 0.29%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -37.91 -40.57 -33.26 -4.23 -37.88 -30.37 -25.17 31.29%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 21.07%
EPS Diluted -0.16 -0.21 -0.15 -0.02 -0.18 -0.14 -0.12 21.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.